163 related articles for article (PubMed ID: 34818692)
1. The clinical characteristics and prognosis of Chinese acute myeloid leukemia patients with CSF3R mutations.
Chen X; Xu J; Fang F; Xu Z; Tan Y; Chang J; Muyey DM; Wang H
Int J Lab Hematol; 2022 Apr; 44(2):364-370. PubMed ID: 34818692
[TBL] [Abstract][Full Text] [Related]
2. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
[TBL] [Abstract][Full Text] [Related]
3. [Impact of
Li RQ; Wen XL; Zhang XL; Dong CX; Wang MF; Liu XX; Huang YJ; Tan YH; Chang JM; Zhang RJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):628-632. PubMed ID: 37356918
[TBL] [Abstract][Full Text] [Related]
4. Differential Implications of CSF3R Mutations in t(8;21) and CEBPA Double Mutated Acute Myeloid Leukemia.
Wang B; Wen L; Wang Z; Chen S; Qiu H
Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):393-404. PubMed ID: 34975010
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of
Cui M; Li QY; Lu XZ; Chao HY; Cai XH; Liu J; Hua HY; Wu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1019-1025. PubMed ID: 37551471
[TBL] [Abstract][Full Text] [Related]
6. CSF3R mutations were associated with an unfavorable prognosis in patients with acute myeloid leukemia with CEBPA double mutations.
Su L; Gao S; Tan Y; Lin H; Liu X; Liu S; Yang Y; Sun J; Li W
Ann Hematol; 2019 Jul; 98(7):1641-1646. PubMed ID: 31041512
[TBL] [Abstract][Full Text] [Related]
7. [Restratifying the prognosis of acute myeloid leukemia patients with CEBPA double mutations based on CSF3R mutations and measurable residual disease].
Su L; Tan YH; Lin H; Han W; Yang YP; Liu XL; Sun JN; Liu QJ; Gao SJ
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1021-1027. PubMed ID: 36709108
[No Abstract] [Full Text] [Related]
8. Prevalence and impact of colony stimulating factor 3 receptor (CSF3R) mutations among Egyptian acute myeloid leukemia patients.
Aref S; El-Ghonemy M; Abouzeid T; El-Sabbagh A; El-Baiomy M
Leuk Res; 2014 Jun; 38(6):722-5. PubMed ID: 24746896
[TBL] [Abstract][Full Text] [Related]
9. Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
Adam FC; Szybinski J; Halter JP; Cantoni N; Wenzel F; Leonards K; Brkic S; Passweg JR; Touw I; Maxson JE; Meyer SC
Curr Oncol; 2022 Feb; 29(2):805-815. PubMed ID: 35200567
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia.
Yun JW; Yoon J; Jung CW; Lee KO; Kim JW; Kim SH; Kim HJ
J Clin Lab Anal; 2020 Feb; 34(2):e23064. PubMed ID: 31692115
[TBL] [Abstract][Full Text] [Related]
11. CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group.
Tarlock K; Lamble AJ; Wang YC; Gerbing RB; Ries RE; Loken MR; Brodersen LE; Pardo L; Leonti A; Smith JL; Hylkema TA; Woods WG; Cooper TM; Kolb EA; Gamis AS; Aplenc R; Alonzo TA; Meshinchi S
Blood; 2021 Sep; 138(13):1137-1147. PubMed ID: 33951732
[TBL] [Abstract][Full Text] [Related]
12. Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia.
Braun TP; Coblentz C; Curtiss BM; Coleman DJ; Schonrock Z; Carratt SA; Callahan RL; Maniaci B; Druker BJ; Maxson JE
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13670-13679. PubMed ID: 32471953
[TBL] [Abstract][Full Text] [Related]
13. Effect of the unfolded protein response and oxidative stress on mutagenesis in CSF3R: a model for evolution of severe congenital neutropenia to myelodysplastic syndrome/acute myeloid leukemia.
Sapra A; Jaksik R; Mehta H; Biesiadny S; Kimmel M; Corey SJ
Mutagenesis; 2020 Dec; 35(5):381-389. PubMed ID: 33511998
[TBL] [Abstract][Full Text] [Related]
14. CSF3R and CALR mutations in paediatric myeloid disorders and the association of CSF3R mutations with translocations, including t(8; 21).
Sano H; Ohki K; Park MJ; Shiba N; Hara Y; Sotomatsu M; Tomizawa D; Taga T; Kiyokawa N; Tawa A; Horibe K; Adachi S; Hayashi Y
Br J Haematol; 2015 Aug; 170(3):391-7. PubMed ID: 25858548
[TBL] [Abstract][Full Text] [Related]
15. The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
Maxson JE; Luty SB; MacManiman JD; Paik JC; Gotlib J; Greenberg P; Bahamadi S; Savage SL; Abel ML; Eide CA; Loriaux MM; Stevens EA; Tyner JW
Clin Cancer Res; 2016 Feb; 22(3):757-64. PubMed ID: 26475333
[TBL] [Abstract][Full Text] [Related]
16. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis.
Skokowa J; Steinemann D; Katsman-Kuipers JE; Zeidler C; Klimenkova O; Klimiankou M; Unalan M; Kandabarau S; Makaryan V; Beekman R; Behrens K; Stocking C; Obenauer J; Schnittger S; Kohlmann A; Valkhof MG; Hoogenboezem R; Göhring G; Reinhardt D; Schlegelberger B; Stanulla M; Vandenberghe P; Donadieu J; Zwaan CM; Touw IP; van den Heuvel-Eibrink MM; Dale DC; Welte K
Blood; 2014 Apr; 123(14):2229-37. PubMed ID: 24523240
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of Genomic Landscape in Patients with Acute Myeloid Leukemia].
Wang SM; Zheng HJ; Tian Y; Zhang JM; Yao JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):797-801. PubMed ID: 32552938
[TBL] [Abstract][Full Text] [Related]
18. CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis.
Awad MM; Aladle DA; Abousamra NK; Elghannam DM; Fawzy IM
Hematology; 2013 Mar; 18(2):61-8. PubMed ID: 22990006
[TBL] [Abstract][Full Text] [Related]
19. A Case of Chronic Eosinophilic Leukemia with CSF3R-Mutant Clone and Transformed to Secondary Acute Myeloid Leukemia.
Wu Y; Yang X
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623671
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
Ouyang Y; Qiao C; Chen Y; Zhang SJ
Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]